Home > Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence.

Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence. (2011) Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence. Dublin: Department of Health.

[img] PDF (Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence) - Published Version
56kB

These recommendations have been prepared by the Expert Group on the basis of the Report of the Evaluation of the Suboxone Feasibility Study 2011 conducted by Create Consultancy and also, having regard to the following national and international reports:
• The 2010 HSE report ‘The Introduction of the Opioid Treatment Protocol’
• The 2002 NACD report ‘Use of buprenorphine as an intervention in the treatment of opiate dependency syndrome’.
• The 2007 National Centre for Pharmacoeconomics report ‘Economic Evaluation of Suboxone for the management of opiate addiction’.
• The 2007 UK National Institute for Health and Clinical Excellence (NICE) guidelines ‘Methadone and buprenorphine for the management of opioid dependence’.

These recommendations apply to the use of medicinal products containing buprenorphine / naloxone, or buprenorphine-only where appropriate, which have been authorised for use in the treatment of opioid dependence. It is not intended that the content of these recommendations would apply to the use of buprenorphine products for the treatment of pain and other indications.


Date:August 2011
Pages:8 p.
Publisher:Department of Health
Corporate Creators:Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence
Place of Publication:Dublin
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Drugs and alcohol substances > Opioids (opiates)
B Drugs and alcohol substances > Opioids (opiates) > Opioid product > Naloxone
B Drugs and alcohol substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment method > Drugs and alcohol disorder treatment method > Drugs and alcohol disorder drug therapy
HJ Treatment method > Drugs and alcohol disorder treatment method > Drugs and alcohol replacement method (substitution)
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page